From: Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations
case1 | case2 | case3 | case4 | case5 | case6 | case7 | case8 | case9 | case 10 | case 11 | |
---|---|---|---|---|---|---|---|---|---|---|---|
CAM5.2 | + | + | + | + | + | + | + | + | + | + | + |
Syn | + | + | + | + | + | + | + | + | + | + | + |
PDX1 | + | + | + | + | + | + | + | + | + | + | + |
CK8/18 | + | + | + | + | + | + | + | + | + | + | + |
β-Tub | + | ± | + | + | + | + | + | ± | + | ± | + |
CD56 | + | + | + | + | + | + | + | + | + | + | ± |
CD34 | − | − | − | ± | − | − | − | ± | − | ± | − |
CD31 | − | − | − | − | − | − | − | − | ± | − | − |
INHa | − | ± | − | − | ± | − | − | − | − | − | − |
AFP | − | − | − | − | − | − | − | − | − | − | − |
P53 | − | − | − | − | − | − | − | − | − | − | − |
Ki-67 | 5% | 8% | 4% | 3% | 10% | 5% | 6% | 3% | 7% | 6% | 4% |
Hep | − | − | − | − | − | − | − | − | − | − | − |